Post-market surveillance is an ongoing process where the FDA monitors the safety of products after they have been released to the market. This involves collecting and analyzing adverse event reports and other data to identify any potential health risks. If new toxicological concerns arise, the FDA can take action, such as updating warnings, modifying usage recommendations, or even withdrawing the product from the market.
